These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
153 related items for PubMed ID: 6788847
1. Activation of macrophages for tumor cell cytotoxicity: identification of indomethacin sensitive and insensitive pathways. Drysdale BE, Shin HS. J Immunol; 1981 Aug; 127(2):760-5. PubMed ID: 6788847 [Abstract] [Full Text] [Related]
2. Lymphokine maintains macrophage activation for tumor cell killing by interfering with the negative regulatory effect of prostaglandin E2. Taffet SM, Pace JL, Russell SW. J Immunol; 1981 Jul; 127(1):121-4. PubMed ID: 6263971 [Abstract] [Full Text] [Related]
9. Differences in antibody-dependent cellular cytotoxicity and activated killing of tumor cells by macrophage cell lines. Ralph P, Nakoinz I. Cancer Res; 1981 Sep; 41(9 Pt 1):3546-50. PubMed ID: 6973392 [Abstract] [Full Text] [Related]
10. Activation of mouse macrophages for tumor cell killing. I. Quantitative analysis of interactions between lymphokine and lipopolysaccharide. Pace JL, Russell SW. J Immunol; 1981 May; 126(5):1863-7. PubMed ID: 7217671 [Abstract] [Full Text] [Related]
11. Differential sensitivity of metastatic versus nonmetastatic mammary tumor cells to macrophage-mediated cytostasis. Yamashina K, Fulton A, Heppner G. J Natl Cancer Inst; 1985 Oct; 75(4):765-70. PubMed ID: 3862907 [Abstract] [Full Text] [Related]
12. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation. Meltzer MS. J Immunol; 1981 Jul; 127(1):179-83. PubMed ID: 7240741 [No Abstract] [Full Text] [Related]
14. Variable effects of indomethacin and four related compounds on lymphocyte blastogenesis and cell-mediated cytotoxicity. Rojo JM, Barasoain I, Portolés A. Int J Clin Pharmacol Ther Toxicol; 1981 Sep; 19(9):420-4. PubMed ID: 6795137 [Abstract] [Full Text] [Related]
15. The effect of adherence on the in vitro induction of cytocidal activity by macrophages. Friedman A, Beller DI. Immunology; 1987 Aug; 61(4):469-74. PubMed ID: 3127324 [Abstract] [Full Text] [Related]
16. Inhibition of macrophage tumoricidal activity by immune complexes and altered erythrocytes. Esparza I, Green R, Schreiber RD. J Immunol; 1983 Nov; 131(5):2117-21. PubMed ID: 6415160 [Abstract] [Full Text] [Related]
17. In vitro induction of tumoricidal and suppressor macrophages by lymphokines: possible feedback regulation. Taramelli D, Holden HT, Varesio L. J Immunol; 1981 Jun; 126(6):2123-8. PubMed ID: 6453155 [Abstract] [Full Text] [Related]
18. Defective tumoricidal capacity of macrophages from P/J mice: characterization of the macrophage cytotoxic defect after in vivo and in vitro activation stimuli. Boraschi D, Meltzer MS. J Immunol; 1980 Aug; 125(2):771-6. PubMed ID: 6993562 [Abstract] [Full Text] [Related]
19. Taxol provides a second signal for murine macrophage tumoricidal activity. Manthey CL, Perera PY, Salkowski CA, Vogel SN. J Immunol; 1994 Jan 15; 152(2):825-31. PubMed ID: 7506736 [Abstract] [Full Text] [Related]
20. Activation of tumor-cytostatic macrophages with the antitumor agent 9,10-anthracenedicarboxaldehyde bis[(4,5-dihydro-1H-imidazole-2-yl)hydrazone] dihydrochloride (bisantrene). Wang BS, Lumanglas AL, Ruszala-Mallon VM, Durr FE. Cancer Res; 1984 Jun 15; 44(6):2363-7. PubMed ID: 6426780 [Abstract] [Full Text] [Related] Page: [Next] [New Search]